Basic Information
| RNALocate ID: | RLID:01001317 |
| RNA Symbol: | hsa-miR-22-3p |
| Localization: | Mitochondrion |
RNA Information
| RNA Name: | hsa-miR-22 |
| RNA ID: | miRBase:MIMAT0000077 |
| RNA Category: | miRNA |
| Species: | Homo sapiens |
Localization Information
| PubMed ID: | 21637849 |
| Tissue/Cell Line: | Skeletal muscle myoblasts |
| Method: | ISH|qRT-PCR |
| Description: | List of microRNA significantly detected in the mitochondrial mRNA at three increasing mtRNA inputs (1, 5 and 35 uL). Table S3 List of microRNA significantly detected (Cp<35) in the mitochondrial mRNA at the two highest mtRNA inputs (5 and 35 uL). Data are collected from Table 4 and S3. |
Other Subcellular Localization
| RNALocate ID | Localization | Tissue/Cell line | PubMed ID |
| RLID:01001315 | Cytoplasm | Cell line (HeLa) | 21695135 |
| RLID:01001316 | Cytoplasm | Breast adenocarcinoma cells (MCF-7)|Cervical adenocarcinoma cells (HeLa) | 24918059 |
| RLID:01001318 | Mitochondrion | Cell line (HEK-293|HeLa) | 22984580 |
| RLID:01001319 | Nucleus | Breast adenocarcinoma cells (MCF-7)|Cervical adenocarcinoma cells (HeLa) | 24918059 |
| RLID:01001320 | Nucleolus | Breast adenocarcinoma cells (MCF-7)|Cervical adenocarcinoma cells (HeLa) | 24918059 |
| RLID:11000790 | Apoptotic body | Human umbilical vein endothelial cells | 19996457 |
| RLID:11000791 | Exosome | Pooled sera | 27278097 |
| RLID:11000792 | Exosome | Hepatocellular carcinoma cell line (HepG2)|Lung epithelial carcinoma cell line (A549) | 20615901 |
| RLID:11000793 | Exosome | Primary dendritic cells|T cell line (J77) | 21505438 |
| RLID:11000794 | Exosome | Renal cancer cells | 21670082 |
| RLID:11000795 | Exosome | Ovarian follicular fluid | 22116803 |
| RLID:11000796 | Exosome | Brain tissue | 23382797 |
| RLID:11000797 | Exosome | Plasma | 23663360 |
| RLID:11000798 | Exosome | Human mast cell line (HMC-1) | 24009880 |
| RLID:11000799 | Exosome | Cerebrospinal fluid | 25420022 |
| RLID:11000800 | Extracellular vesicle | HEK-293T cells | 22849433 |
| RLID:11000801 | Microvesicle | Hepatocellular carcinoma cell line (HepG2)|Lung epithelial carcinoma cell line (A549) | 20615901 |
| RLID:11000802 | Microvesicle | Plasma | 23077538 |
| RLID:11000803 | Microvesicle | Seminal plasma | 23539611 |
| RLID:11000804 | Microvesicle | Hepatoma cells | 23771658 |
| RLID-D:11000014 | Exosome | Blood|B lymphoblastoid cells|Breast milk|Chronic lymphocytic leukemia cells|Colon tissue|Endothelial cells|Epithelial cells|Kidney tissue|Lymphoma tissue|Mast cells|Seminal fluid|Tongue tissue | |
| RLID-D:11000276 | Microvesicle | Blood|Breast cell line|Colon cancer cell line (LIM1863)|Fibroblasts|Mesenchymal stem cells|Urine |
ncRNA Disease Information
| Resource | RNA Symbol | Disease | Link |
| MNDR | hsa-miR-22-3p | Multiple sclerosis chronic progressive | MNDR-E-MI-31308 |
| MNDR | hsa-miR-22-3p | Oral squamous cell carcinoma | MNDR-E-MI-31309 |
| MNDR | hsa-miR-22-3p | Large cell neuroendocrine cancer | MNDR-E-MI-31310 |
| MNDR | hsa-miR-22-3p | Medulloblastoma | MNDR-E-MI-31311 |
| MNDR | hsa-miR-22-3p | Myelodysplastic syndrome | MNDR-E-MI-31312 |
| MNDR | hsa-miR-22-3p | Lymphoma | MNDR-E-MI-31313 |
| MNDR | hsa-miR-22-3p | Estrogen-receptor positive breast cancer | MNDR-E-MI-31314 |
| MNDR | hsa-miR-22-3p | Progesterone-receptor positive breast cancer | MNDR-E-MI-31315 |
| MNDR | hsa-miR-22-3p | Progesterone-receptor negative breast cancer | MNDR-E-MI-31316 |
| MNDR | hsa-miR-22-3p | Her2-receptor positive breast cancer | MNDR-E-MI-31317 |
| MNDR | hsa-miR-22-3p | Anencephaly | MNDR-E-MI-31318 |
| MNDR | hsa-miR-22-3p | Niemann-pick disease type c | MNDR-E-MI-31319 |
| MNDR | hsa-miR-22-3p | Precursor cell lymphoblastic leukemia-lymphoma | MNDR-E-MI-31320 |
| MNDR | hsa-miR-22-3p | Dermatomyositis | MNDR-E-MI-31321 |
| MNDR | hsa-miR-22-3p | Prostate cancer | MNDR-E-MI-31322 |
| MNDR | hsa-miR-22-3p | Chronic lymphocytic leukemia | MNDR-E-MI-31323 |
| MNDR | hsa-miR-22-3p | Gastric cancer | MNDR-E-MI-31324 |
| MNDR | hsa-miR-22-3p | Alzheimer disease | MNDR-E-MI-31325 |
| MNDR | hsa-miR-22-3p | Intracranial aneurysm | MNDR-E-MI-31326 |
| MNDR | hsa-miR-22-3p | Bladder cancer | MNDR-E-MI-31327 |
| MNDR | hsa-miR-22-3p | Esophageal carcinoma | MNDR-E-MI-31328 |
| MNDR | hsa-miR-22-3p | Dysautonomia familial | MNDR-E-MI-31329 |
| MNDR | hsa-miR-22-3p | Myotonic dystrophy | MNDR-E-MI-31330 |
| MNDR | hsa-miR-22-3p | Muscular dystrophy duchenne | MNDR-E-MI-31331 |
| MNDR | hsa-miR-22-3p | Head and neck cancer | MNDR-E-MI-31332 |
| MNDR | hsa-miR-22-3p | Graves disease | MNDR-E-MI-31333 |
| MNDR | hsa-miR-22-3p | Malaria | MNDR-E-MI-31334 |
| MNDR | hsa-miR-22-3p | Leukemia | MNDR-E-MI-31335 |
| MNDR | hsa-miR-22-3p | Huntington disease | MNDR-E-MI-31336 |
| MNDR | hsa-miR-22-3p | Chorea | MNDR-E-MI-31337 |
| MNDR | hsa-miR-22-3p | Cardiovascular disease | MNDR-E-MI-31338 |
| MNDR | hsa-miR-22-3p | Carotid stenosis | MNDR-E-MI-31339 |
| MNDR | hsa-miR-22-3p | Moyamoya disease | MNDR-E-MI-31340 |
| MNDR | hsa-miR-22-3p | Lung cancer | MNDR-E-MI-31341 |
| MNDR | hsa-miR-22-3p | Down syndrome | MNDR-E-MI-31342 |
| MNDR | hsa-miR-22-3p | Parkinson disease | MNDR-E-MI-31343 |
| MNDR | hsa-miR-22-3p | Niemann-pick disease | MNDR-E-MI-31344 |
| MNDR | hsa-miR-22-3p | Thrombocytopenia | MNDR-E-MI-31345 |
| MNDR | hsa-miR-22-3p | Breast cancer | MNDR-E-MI-31346 |
| MNDR | hsa-miR-22-3p | Pituitary neoplasms | MNDR-E-MI-31347 |
| MNDR | hsa-miR-22-3p | Pancreatic cancer | MNDR-E-MI-31348 |
| MNDR | hsa-miR-22-3p | Melanoma | MNDR-E-MI-31349 |
| MNDR | hsa-miR-22-3p | Rectum adenocarcinoma | MNDR-E-MI-31350 |
| MNDR | hsa-miR-22-3p | Nephroblastoma | MNDR-E-MI-31351 |
| MNDR | hsa-miR-22-3p | Colon cancer | MNDR-E-MI-31352 |
| MNDR | hsa-miR-22-3p | Colon adenocarcinoma | MNDR-E-MI-31353 |
| MNDR | hsa-miR-22-3p | Multiple sclerosis relapsing-remitting | MNDR-E-MI-31354 |
| MNDR | hsa-miR-22-3p | Familial ovarian cancer | MNDR-E-MI-31355 |
| MNDR | hsa-miR-22-3p | Prostate adenocarcinoma | MNDR-E-MI-31356 |
| MNDR | hsa-miR-22-3p | Kidney cancer | MNDR-E-MI-31357 |
| MNDR | hsa-miR-22-3p | Asthma | MNDR-E-MI-31358 |
| MNDR | hsa-miR-22-3p | Carcinoma ductal breast | MNDR-E-MI-31359 |
| MNDR | hsa-miR-22-3p | Glioblastoma | MNDR-E-MI-31360 |
| MNDR | hsa-miR-22-3p | Glioma | MNDR-E-MI-31361 |
| MNDR | hsa-miR-22-3p | Chronic obstructive pulmonary disease | MNDR-E-MI-31362 |
| MNDR | hsa-miR-22-3p | Amyotrophic lateral sclerosis | MNDR-E-MI-31363 |
| MNDR | hsa-miR-22-3p | Osteosarcoma | MNDR-E-MI-31364 |
| MNDR | hsa-miR-22-3p | Coronary artery disease | MNDR-E-MI-31365 |
| MNDR | hsa-miR-22-3p | Inclusion body myositis | MNDR-E-MI-31366 |
| MNDR | hsa-miR-22-3p | Meningioma | MNDR-E-MI-31367 |
| MNDR | hsa-miR-22-3p | Liver cancer | MNDR-E-MI-31368 |
| MNDR | hsa-miR-22-3p | Uterine cancer | MNDR-E-MI-31369 |
| MNDR | hsa-miR-22-3p | Gastric adenocarcinoma | MNDR-E-MI-31370 |
| MNDR | hsa-miR-22-3p | Cervical squamous cell carcinoma | MNDR-E-MI-31371 |
| MNDR | hsa-miR-22-3p | Pituitary adenoma | MNDR-E-MI-31372 |
| MNDR | hsa-miR-22-3p | Lung squamous cell carcinoma | MNDR-E-MI-31373 |
| MNDR | hsa-miR-22-3p | Lung adenocarcinoma | MNDR-E-MI-31374 |
| MNDR | hsa-miR-22-3p | Adrenocortical cancer | MNDR-E-MI-31375 |
| MNDR | hsa-miR-22-3p | Thyroid carcinoma | MNDR-E-MI-31376 |
| MNDR | hsa-miR-22-3p | Pancreatic adenocarcinoma | MNDR-E-MI-31377 |
| MNDR | hsa-miR-22-3p | Brain stem cancer | MNDR-E-MI-31378 |
| MNDR | hsa-miR-22-3p | Carcinoma renal cell | MNDR-E-MI-31379 |
| MNDR | hsa-miR-22-3p | Intrahepatic cholangiocarcinoma | MNDR-E-MI-31380 |
| MNDR | hsa-miR-22-3p | Cholangiocarcinoma | MNDR-E-MI-31381 |
| MNDR | hsa-miR-22-3p | Esophageal cancer | MNDR-E-MI-31382 |
| MNDR | hsa-miR-22-3p | Oncocytoma | MNDR-E-MI-31383 |
| MNDR | hsa-miR-22-3p | Lung small cell carcinoma | MNDR-E-MI-31384 |
| MNDR | hsa-miR-22-3p | Head and neck squamous cell carcinoma | MNDR-E-MI-31385 |
| MNDR | hsa-miR-22-3p | T acute lymphoblastic leukemia | MNDR-E-MI-31386 |
| MNDR | hsa-miR-22-3p | Acute t cell leukemia | MNDR-E-MI-31387 |
| MNDR | hsa-miR-22-3p | Fibromyalgia | MNDR-E-MI-31388 |
| MNDR | hsa-miR-22-3p | Encephalomyelitis | MNDR-E-MI-31389 |
| MNDR | hsa-miR-22-3p | Adenoma | MNDR-E-MI-31390 |
| MNDR | hsa-miR-22-3p | Breast invasive carcinoma | MNDR-E-MI-31391 |
| MNDR | hsa-miR-22-3p | Early hepatocellular carcinoma | MNDR-E-MI-31392 |
| MNDR | hsa-miR-22-3p | Familiar ovarian carcinoma | MNDR-E-MI-31393 |
| MNDR | hsa-miR-22-3p | B-cell lymphoma | MNDR-E-MI-31394 |
| MNDR | hsa-miR-22-3p | Rheumatoid arthritis | MNDR-E-MI-31395 |
| MNDR | hsa-miR-22-3p | Hodgkin lymphoma | MNDR-E-MI-31396 |
| MNDR | hsa-miR-22-3p | Burkitt lymphoma | MNDR-E-MI-31397 |
| MNDR | hsa-miR-22-3p | Neuromyelitis optica | MNDR-E-MI-31398 |
| MNDR | hsa-miR-22-3p | Psoriasis | MNDR-E-MI-31399 |
| MNDR | hsa-miR-22-3p | Acute myelocytic leukemia | MNDR-E-MI-31400 |
| MNDR | hsa-miR-22-3p | Colorectal cancer | MNDR-E-MI-31401 |
| MNDR | hsa-miR-22-3p | Nasopharynx carcinoma | MNDR-E-MI-31402 |
| MNDR | hsa-miR-22-3p | Pulmonary emphysema | MNDR-E-MI-31403 |
| MNDR | hsa-miR-22-3p | Acute lymphocytic leukemia | MNDR-E-MI-31404 |
| MNDR | hsa-miR-22-3p | Hyperalgesia | MNDR-E-MI-31405 |
| MNDR | hsa-miR-22-3p | Nasopharyngeal cancer | MNDR-E-MI-31406 |
| MNDR | hsa-miR-22-3p | Sleep deprivation | MNDR-E-MI-31407 |
| MNDR | hsa-miR-22-3p | Epstein-barr virus infections | MNDR-E-MI-31408 |
| MNDR | hsa-miR-22-3p | Cerebral hemorrhage traumatic | MNDR-E-MI-31409 |
| MNDR | hsa-miR-22-3p | Intracranial hemorrhage hypertensive | MNDR-E-MI-31410 |
| MNDR | hsa-miR-22-3p | Sarcopenia | MNDR-E-MI-31411 |
| MNDR | hsa-miR-22-3p | Peripheral nerve injuries | MNDR-E-MI-31412 |
| MNDR | hsa-miR-22-3p | Stroke lacunar | MNDR-E-MI-31413 |
| MNDR | hsa-miR-22-3p | Non-alcoholic fatty liver disease | MNDR-E-MI-31414 |
| MNDR | hsa-miR-22-3p | High grade dysplastic nodule | MNDR-E-MI-31415 |
| MNDR | hsa-miR-22-3p | Tubulovillous adenoma | MNDR-E-MI-31416 |
RNA Interaction Information
| Resource | RNA Symbol | Species | Link | RNALocate ID |
| RNAInter | ACLY | Homo sapiens | RR00034414 |
TOP